FAPI-04

P011
Grade:
GMP product
Tested for sterility and bacterial endotoxins
Description:
Chemical precursor for ⁶⁸Ga-FAPI-04.
FAPI-04 is a potent fibroblast activation protein (FAP) inhibitor used for targeting FAP-expressing tissues.
It is applied in cancer research and diagnostics, particularly for identifying oral carcinoma.
⁶⁸Ga-FAPI-04 PET/CT is a promising method for imaging various tumor types, offering high tumor-to-background contrast.
Molar weight:
872.91 g/mol (net substance)
Molecular formula:
C₄₀H₅₄F₂N₁₀O₁₀ (net substance)
CAS №:
2374782-02-0
PubChem CID:
155776444
Retest date:
Not less than 18 months from the manufacturing date
Packaging:
2R/4ml or 8R/10ml Type I glass vials with bromobutyl rubber stoppers
Storage conditions:
–20 ±5 °C
Transportation at 2–8 °C (less than 1 month)
Available quantities:
0.1 mg; 1.0 mg; custom quantity upon request
Quality parameters

Quality parameters

Appearance: White solid
Identification:
– HPLC: Retention time of main peak corresponds to the FAPI-04 reference standard
– Mass spectrometry: m/z = 872.9 ± 4
Residual heavy metals (ICP-OES): ≤ 100 ppm
Purity (HPLC): ≥ 98.0%
Bacterial endotoxins (gel-clot method): ≤ 10.0 EU/vial
Sterility (direct inoculation method): Sterile (passes test)
Sterility tests are performed for sterile products, made in aseptic conditions (class A).
Other products